12/12 Yahoo! Finance: PFE News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Yahoo! Finance: PFE News - Latest Financial News for PFIZER INC Nexavar may help breast cancer drugs work longer (at Reuters) December 11, 2009 at 9:00 pm ETFs Stay 'Focused' With Big Stakes (at TheStreet.com) December 11, 2009 at 4:24 pm Health-Care Reform for Dummies (at Motley Fool) December 11, 2009 at 4:01 pm Roche and Biogen's Blockbuster Making Good Progress (at Motley Fool) December 11, 2009 at 2:36 pm UPDATE - US panel to weigh safety of AstraZeneca's Crestor (at Reuters) December 11, 2009 at 2:09 pm Gilead Gets the Experts on Its Side (at Motley Fool) December 11, 2009 at 2:08 pm Why a return to boring would be very welcome (at FT.com) December 11, 2009 at 2:05 pm There is not a single investment play that was "boring" in the last 12 months. That includes even the staid world of stock dividends, not often regarded as the raciest of investment ploys. FDA confirms benefits of Crestor in more patients (AP) December 11, 2009 at 11:28 am Federal scientists say AstraZeneca's cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain. LLY: Caris Cuts to "Hold" (at Barrons.com) December 11, 2009 at 11:25 am Expect More of This in 2010 (at Motley Fool) December 11, 2009 at 10:39 am Eli Lilly Isn't Planning to Buy Its Way Around the Patent Cliff (at The Wall Street Journal Online) December 11, 2009 at 10:05 am Pfizer children's vaccine receives European OK (AP) December 11, 2009 at 7:54 am Pfizer Inc. said Friday European regulators have approved a new version of its children's pneumococcal vaccine, Prevenar 13. UPDATE - Pfizer wins Europe approval for new vaccine (at Reuters) December 11, 2009 at 7:50 am Pfizer gets European authorization for Prevenar 13 (at MarketWatch) December 11, 2009 at 6:02 am Showdown Over AIDS Drugs (at Forbes.com) December 11, 2009 at 6:00 am Pfizer Receives European Authorization For Prevenar 13* For The Prevention Of Pneumococcal Disease In Infants And Young Children (Business Wire) December 11, 2009 at 5:52 am NEW YORK----The European Commission has granted Pfizer Inc. a European marketing authorization for its pneumococcal conjugate vaccine, Prevenar 13* . Prevenar 13 is indicated for active immunization for the prevention of invasive disease, pneumonia, and acute otitis media caused by 13 Streptococcus pneumoniae serotypes in infants and children from 6 weeks to 5 years of age. Pfizer Forms Cancer Collaboration with Crown Bioscience (at Seeking Alpha) December 11, 2009 at 2:31 am Pfizer's R&D: Spending vs. Productivity (at Seeking Alpha) December 11, 2009 at 2:17 am 5 Cheapest Dogs of the Dow (Zacks.com) December 11, 2009 at 1:00 am These 5 Dogs of the Dow have a twist of value to compliment their hefty dividend yields.   This email was sent to gatdemit001@gmail.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.